Miroslav Dostálek
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 15
- Drug-Induced Hepatotoxicity and Protection 5
- Ophthalmology top 2%
- Retinal Diseases and Treatments 3
- Biochemistry top 5%
-
- Monoclonal and Polyclonal Antibodies Research 4
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 4
-
- Drug Transport and Resistance Mechanisms 6
-
- Glycosylation and Glycoproteins Research 4
- Metabolomics and Mass Spectrometry Studies 3
- Co-authors
- Fatemeh AkhlaghiIain GardnerBrian M. GurbaxaniF. Peter GuengerichManoranjenni ChettyRachel H. RoseMichael H. CourtBingfang Yan
- Journals
- Journal of Biological Chemistry (1 paper)British Journal of Pharmacology (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesCzechiaSwitzerland
In The Last Decade
Miroslav Dostálek
42 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 113
- Pharmacology 367
- Ophthalmology 212
- Biochemistry 127
- Radiology, Nuclear Medicine and Imaging 384
- Transplantation 42
Countries citing papers authored by Miroslav Dostálek
This map shows the geographic impact of Miroslav Dostálek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miroslav Dostálek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miroslav Dostálek more than expected).
Fields of papers citing papers by Miroslav Dostálek
This network shows the impact of papers produced by Miroslav Dostálek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miroslav Dostálek. The network helps show where Miroslav Dostálek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miroslav Dostálek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 7 | |
| 2 | 2016 | 241 | |
| 3 | 2014 | 51 | |
| 4 | 2013 | 184 | |
| 5 | 2013 | 47 | |
| 6 | 2012 | 101 | |
| 7 | 2012 | 98 | |
| 8 | 2011 | 38 | |
| 9 | 2011 | 6 | |
| 10 | 2011 | 110 | |
| 11 | 2010 | 34 | |
| 12 | 2010 | 17 | |
| 13 | 2009 | 32 | |
| 14 | 2008 | 62 | |
| 15 | 2007 | 37 | |
| 16 | 2007 | 19 | |
| 17 | Feet of methamphetamine on pharmacokinetics of dextromethorphanand midazolam in rats. | 2005 | 1 |
| 18 | 2005 | 1 | |
| 19 | Effect of methamphetamine and fluoxetine combination onmethabolic activity of CYP2D2 in isolated perfused liver | 2003 | 1 |
| 20 | 1999 | 14 |
About Miroslav Dostálek
Miroslav Dostálek is a scholar working on Pharmacology, Transplantation and Ophthalmology, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Glycosylation and Glycoproteins Research (4 papers), Renal Transplantation Outcomes and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Pharmacology (367 citations), Ophthalmology (212 citations) and Biochemistry (127 citations). Miroslav Dostálek has collaborated with scholars based in United States, Czechia and Switzerland. Frequent co-authors include Fatemeh Akhlaghi, Iain Gardner, Brian M. Gurbaxani, F. Peter Guengerich, Manoranjenni Chetty, Rachel H. Rose, Michael H. Court, Bingfang Yan, Katarina Stark and Suzanne M. de la Monte. Their work appears in journals such as Journal of Biological Chemistry, British Journal of Pharmacology and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.